ALYREF and gastric adenocarcinoma: Among the 32 types of cancer, 29 showed an increased level of ALYREF in tumors tissues than in normal tissues, including STAD, liver hepatocellular carcinoma (LIHC), and Pan-kidney cohort (KIPAN) (Fig. 1a).